Drug Resistance, Bacterial
"Drug Resistance, Bacterial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).
| Descriptor ID |
D024881
|
| MeSH Number(s) |
G06.099.225 G06.225.347 G07.690.773.984.269.347
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Drug Resistance, Bacterial".
Below are MeSH descriptors whose meaning is more specific than "Drug Resistance, Bacterial".
This graph shows the total number of publications written about "Drug Resistance, Bacterial" by people in this website by year, and whether "Drug Resistance, Bacterial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2002 | 1 | 2 | 3 |
| 2003 | 0 | 7 | 7 |
| 2004 | 1 | 5 | 6 |
| 2005 | 7 | 5 | 12 |
| 2006 | 6 | 7 | 13 |
| 2007 | 4 | 5 | 9 |
| 2008 | 4 | 9 | 13 |
| 2009 | 3 | 4 | 7 |
| 2010 | 3 | 5 | 8 |
| 2011 | 5 | 5 | 10 |
| 2012 | 6 | 3 | 9 |
| 2013 | 9 | 9 | 18 |
| 2014 | 5 | 8 | 13 |
| 2015 | 6 | 12 | 18 |
| 2016 | 6 | 8 | 14 |
| 2017 | 4 | 11 | 15 |
| 2018 | 5 | 9 | 14 |
| 2019 | 5 | 5 | 10 |
| 2020 | 6 | 8 | 14 |
| 2021 | 3 | 10 | 13 |
| 2022 | 2 | 8 | 10 |
| 2023 | 1 | 8 | 9 |
| 2024 | 6 | 7 | 13 |
| 2025 | 14 | 1 | 15 |
| 2026 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Resistance, Bacterial" by people in Profiles.
-
Personalized Antibiogram: A Novel Multitask Machine Learning Framework for Simultaneous Prediction of Antimicrobial Resistance Profile With Enhanced Detection of Carbapenem Resistance in Enterobacteriaceae. Clin Infect Dis. 2026 Jul 23; 83(1):e1-e9.
-
Lack of knowledge of antibiotic risks among outpatients is associated with intention to use antibiotics without a prescription. Expert Rev Anti Infect Ther. 2026 Jul; 24(7):713-719.
-
Low-Abundance and Fragmentary Helicobacter pylori DNA Detected in Phenotypically Negative Gastric Biopsies Using Targeted Sequencing. Biomolecules. 2026 May 22; 16(6).
-
Advancing antimicrobial therapy: evaluating the ASTar (Q-linea) System for rapid AST in Gram-negative bloodstream infections. Microbiol Spectr. 2026 Jun 02; 14(6):e0358125.
-
The Unfinished Agenda in Helicobacter pylori Treatment: Resistance, Microbiome Effects, and Future Directions. Gastroenterology. 2026 Aug; 171(2):271-284.
-
Insights Into Global Antimicrobial Resistance Dynamics Through the Sequencing of Enteric Bacteria From US International Travelers. J Infect Dis. 2026 Jan 17; 233(1):e164-e173.
-
Microbiological profile and antibiotic resistance trends of preoperative conjunctival swabs: An 8-year retrospective analysis from a North Indian tertiary care ophthalmic center. Indian J Ophthalmol. 2026 01 01; 74(1):98-103.
-
Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study. Lancet Microbe. 2026 Jan; 7(1):101217.
-
Efficacy of fourteen-day once-daily vonoprazan-based quadruple therapy for Helicobacter pylori in high clarithromycin-resistance regions (ONCE-VONO Trial). Sci Rep. 2025 12 18; 15(1):44105.
-
GeoSentinel Analysis of Travelers' Diarrhea Antimicrobial Resistance Patterns. JAMA Netw Open. 2025 12 01; 8(12):e2551089.